Great news for India’s health, as Covid-19 vaccine, Covaxin for children aged between 2 to 18 years, gains approval.
Covaxin is developed and manufactured by Bharat Biotech. The vaccine aims at protecting against COVID-19. Emergency use approval has been provided to Covaxin for use on children of the age group 2 to 18 years.
Bharat Biotech International Limited is an Indian multinational biotechnology company based in Hyderabad.
The company in September 2021, had completely carried out Phase-II and Phase-III trials of its vaccine, Covaxin, on children below 18 years of age. It had submitted the trial to the Drugs and Comptroller General of India (DCGI) in the beginning of October.